300676 华大基因
交易中 12-24 13:51:30
资讯
新帖
简况
华大基因获得发明专利授权：“一种用于宏基因组学病原体检测参考阈值建立的方法”
证券之星 · 12-19
华大基因获得发明专利授权：“一种用于宏基因组学病原体检测参考阈值建立的方法”
华大基因：12月12日接受机构调研，投资者参与
证券之星 · 12-13
华大基因：12月12日接受机构调研，投资者参与
华大基因新注册《一种基于时空测序技术识别微血管结构的软件V1.0》项目的软件著作权
证券之星 · 12-10
华大基因新注册《一种基于时空测序技术识别微血管结构的软件V1.0》项目的软件著作权
华大基因（300676）12月6日主力资金净买入2641.37万元
证券之星 · 12-09
华大基因（300676）12月6日主力资金净买入2641.37万元
华大基因新注册《qPCR变异验证软件V1.0.0》等3个项目的软件著作权
证券之星 · 12-07
华大基因新注册《qPCR变异验证软件V1.0.0》等3个项目的软件著作权
华大基因新注册《基于空间邻域的空间转录组细胞类型生态位分析软件V1.0》项目的软件著作权
证券之星 · 12-07
华大基因新注册《基于空间邻域的空间转录组细胞类型生态位分析软件V1.0》项目的软件著作权
美国立法者正考虑对生物安全法案进行更改？华大基因投资者关系部回应：没有了解到此消息
美港电讯 · 12-06
美国立法者正考虑对生物安全法案进行更改？华大基因投资者关系部回应：没有了解到此消息
华大基因新注册《基于长读长转录组的引物检测及去除软件V1.0》项目的软件著作权
证券之星 · 11-30
华大基因新注册《基于长读长转录组的引物检测及去除软件V1.0》项目的软件著作权
华大基因：11月27日高管赵立见增持股份合计6500股
证券之星 · 11-28
华大基因：11月27日高管赵立见增持股份合计6500股
华大基因(300676.SZ)多位董高完成增持 累计增持25.72万股
智通财经 · 11-28
华大基因(300676.SZ)多位董高完成增持 累计增持25.72万股
华大基因：11月26日高管赵立见增持股份合计5.86万股
证券之星 · 11-27
华大基因：11月26日高管赵立见增持股份合计5.86万股
华大基因高管频繁增持背后：净利润首亏与研发转化率降低成焦点
大消费之家 · 11-27
华大基因高管频繁增持背后：净利润首亏与研发转化率降低成焦点
华大基因实控人罕见方式增持
媒体滚动 · 11-27
华大基因实控人罕见方式增持
华大基因：华大控股计划以大宗交易方式减持不超2%公司股份
中国财富通 · 11-26
华大基因：华大控股计划以大宗交易方式减持不超2%公司股份
11月25日上市公司减持汇总：华大基因等8股拟减持（表）
新浪证券 · 11-25
11月25日上市公司减持汇总：华大基因等8股拟减持（表）
华大基因实控人汪建收购王俊全部股份，持股比例持续提升
格隆汇APP · 11-25
华大基因实控人汪建收购王俊全部股份，持股比例持续提升
华大基因：11月22日高管王玉珏增持股份合计3300股
证券之星 · 11-25
华大基因：11月22日高管王玉珏增持股份合计3300股
华大基因最新公告：控股股东计划减持公司股份不超过2%
证券之星 · 11-25
华大基因最新公告：控股股东计划减持公司股份不超过2%
华大基因：控股股东华大控股拟减持不超2%公司股份
美港电讯 · 11-25
华大基因：控股股东华大控股拟减持不超2%公司股份
华大基因(300676.SZ)控股股东华大控股拟减持不超2%股份
智通财经网 · 11-25
华大基因(300676.SZ)控股股东华大控股拟减持不超2%股份
暂无数据
公司概况
公司名称：
深圳华大基因股份有限公司
所属行业：
专业技术服务业
上市日期：
2017-07-14
主营业务：
深圳华大基因股份有限公司的主营业务为通过基因检测,质谱检测,生物信息分析等多组学大数据技术手段，为科研机构,企事业单位,医疗机构,社会卫生组织等提供研究服务和精准医学检测综合解决方案。公司主要产品包括孕期营养检测、人体氨基酸检测、人体维生素检测等。公司荣获“2022年度ESG最佳社会责任企业”、“2023医疗器械出海最佳战略布局企业”、“2022年度投资者关系金奖杰出IR公司”，“2023环境、社会及治理（ESG）年度案例”等多项社会荣誉或奖项，有效提升了公司的品牌知名度和影响力。
发行价格：
13.64
{"stockData":{"symbol":"300676","market":"SZ","secType":"STK","nameCN":"华大基因","latestPrice":44.1,"timestamp":1735019490000,"preClose":44.12,"halted":0,"volume":1738800,"delay":0,"floatShares":413000000,"shares":416000000,"eps":-0.2444,"marketStatus":"交易中","marketStatusCode":2,"change":-0.02,"latestTime":"12-24 13:51:30","open":44.46,"high":44.77,"low":43.89,"amount":76921800,"amplitude":0.0199,"askPrice":44.12,"askSize":40,"bidPrice":44.1,"bidSize":4,"shortable":0,"etf":0,"ttmEps":-0.2444,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1735023600000},"adr":0,"adjPreClose":44.12,"symbolType":"stock","openAndCloseTimeList":[[1735003800000,1735011000000],[1735016400000,1735023600000]],"highLimit":48.53,"lowLimit":39.71,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":415821575,"pbRate":1.87,"roa":"--","roe":"--","epsLYR":0.2266,"committee":-0.522013,"marketValue":18338000000,"floatMarketCap":18192000000,"peRate":-180.441903,"changeRate":-0.0005,"turnoverRate":0.0042,"status":1},"requestUrl":"/m/hq/s/300676/tweets","defaultTab":"tweets","newsList":[{"id":"2492344291","title":"华大基因获得发明专利授权：“一种用于宏基因组学病原体检测参考阈值建立的方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2492344291","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492344291?lang=zh_cn&edition=full","pubTime":"2024-12-19 02:07","pubTimestamp":1734545234,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示华大基因新获得一项发明专利授权，专利名为“一种用于宏基因组学病原体检测参考阈值建立的方法”，专利申请号为CN202110895536.4，授权日为2024年12月17日。今年以来华大基因新获得专利授权19个，较去年同期增加了11.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121900001889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300676","BK0197","BK0196","BK0046","BK0221","BK0042"],"gpt_icon":0},{"id":"2491938183","title":"华大基因：12月12日接受机构调研，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2491938183","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491938183?lang=zh_cn&edition=full","pubTime":"2024-12-13 09:34","pubTimestamp":1734053640,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年12月12日华大基因发布公告称公司于2024年12月12日接受机构调研。华大基因的业务范围涵盖了基因检测、质谱检测、生物信息分析等多个方面，为科研机构、企事业单位、医疗机构等提供研究服务和精准医学检测综合解决方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300010150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","BK0197","BK0196","BK0221","300676"],"gpt_icon":0},{"id":"2490270315","title":"华大基因新注册《一种基于时空测序技术识别微血管结构的软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2490270315","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490270315?lang=zh_cn&edition=full","pubTime":"2024-12-10 01:21","pubTimestamp":1733764867,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华大基因（300676）新注册了《一种基于时空测序技术识别微血管结构的软件V1.0》项目的软件著作权。今年以来华大基因新注册软件著作权22个，较去年同期减少了35.29%。结合公司2024年中报财务数据，今年上半年公司在研发方面投入了2.5亿元，同比减5.42%。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121000000915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","BK0197","BK0196","BK0221","300676"],"gpt_icon":0},{"id":"2490764017","title":"华大基因（300676）12月6日主力资金净买入2641.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490764017","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490764017?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:14","pubTimestamp":1733706886,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月6日收盘，华大基因报收于47.57元，上涨4.55%，换手率1.53%，成交量6.32万手，成交额2.95亿元。近5日资金流向一览见下表：华大基因融资融券信息显示，融资方面，当日融资买入2820.21万元，融资偿还2938.24万元，融资净偿还118.03万元。华大基因主营业务：通过基因检测、质谱检测、生物信息分析等多组学大数据技术手段,为科研机构、企事业单位、医疗机构、社会卫生组织等提供研究服务和精准医学检测综合解决方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120900002231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","300676","BK0221","BK0196","BK0046","BK0042"],"gpt_icon":0},{"id":"2489908256","title":"华大基因新注册《qPCR变异验证软件V1.0.0》等3个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2489908256","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489908256?lang=zh_cn&edition=full","pubTime":"2024-12-07 01:19","pubTimestamp":1733505550,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华大基因（300676）新注册了3个项目的软件著作权，包括《qPCR变异验证软件V1.0.0》、《MLPA变异验证软件V1.0.0》、《SGS变异验证软件V1.0.0》等。今年以来华大基因新注册软件著作权21个，较去年同期减少了38.24%。结合公司2024年中报财务数据，今年上半年公司在研发方面投入了2.5亿元，同比减5.42%。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120700001524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0221","BK0042","BK0197","300676","BK0196","BK0046"],"gpt_icon":0},{"id":"2489025665","title":"华大基因新注册《基于空间邻域的空间转录组细胞类型生态位分析软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2489025665","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489025665?lang=zh_cn&edition=full","pubTime":"2024-12-07 01:19","pubTimestamp":1733505550,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华大基因（300676）新注册了《基于空间邻域的空间转录组细胞类型生态位分析软件V1.0》项目的软件著作权。今年以来华大基因新注册软件著作权21个，较去年同期减少了38.24%。结合公司2024年中报财务数据，今年上半年公司在研发方面投入了2.5亿元，同比减5.42%。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120700001523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300676","BK0046","BK0196","BK0197","BK0221","BK0042"],"gpt_icon":0},{"id":"2489476946","title":"美国立法者正考虑对生物安全法案进行更改？华大基因投资者关系部回应：没有了解到此消息","url":"https://stock-news.laohu8.com/highlight/detail?id=2489476946","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489476946?lang=zh_cn&edition=full","pubTime":"2024-12-06 14:17","pubTimestamp":1733465865,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["603259","LU2045819591.USD","LU0320764599.SGD","LU1046422090.SGD","BK1576","LU2242644610.SGD","LU0708995583.HKD","LU0052750758.USD","LU1997245177.USD","BK0216","BK0221","BK0042","300676","LU0456842615.SGD","LU2125910500.SGD","LU2488822045.USD","BK1141","BK1583","02359","BK0046","BK0197","LU1997245094.SGD","BK0196"],"gpt_icon":0},{"id":"2487608685","title":"华大基因新注册《基于长读长转录组的引物检测及去除软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2487608685","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487608685?lang=zh_cn&edition=full","pubTime":"2024-11-30 01:21","pubTimestamp":1732900869,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华大基因（300676）新注册了《基于长读长转录组的引物检测及去除软件V1.0》项目的软件著作权。今年以来华大基因新注册软件著作权17个，较去年同期减少了48.48%。结合公司2024年中报财务数据，今年上半年公司在研发方面投入了2.5亿元，同比减5.42%。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024113000001247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0197","300676","BK0046","BK0221","BK0042"],"gpt_icon":0},{"id":"2486316882","title":"华大基因：11月27日高管赵立见增持股份合计6500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486316882","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486316882?lang=zh_cn&edition=full","pubTime":"2024-11-28 21:01","pubTimestamp":1732798890,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月28日市场公开信息、上市公司公告及交易所披露数据整理，华大基因最新董监高及相关人员股份变动情况：2024年11月27日公司董事,高管赵立见共增持公司股份6500.0股，占公司总股本为0.0016%。变动期间公司股价上涨1.3%，11月27日当日收盘报45.22元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112800036445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","300676","BK0221","BK0196","BK0046","BK0042"],"gpt_icon":0},{"id":"2486139931","title":"华大基因(300676.SZ)多位董高完成增持 累计增持25.72万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486139931","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486139931?lang=zh_cn&edition=full","pubTime":"2024-11-28 18:22","pubTimestamp":1732789332,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华大基因(300676.SZ)公告，公司近日收到董事、总经理赵立见，董事、副总经理、财务总监王玉珏，副总经理、董事会秘书徐茜出具的《关于对深圳华大基因股份有限公司股份增持计划实施完成的告知函》，截至2024年11月27日，本次增持计划已实施完成。自增持计划披露日(2024年5月30日)至2024年11月27日，本次增持计划实施主体通过集中竞价交易方式累计增持公司股份25.72万股，占公司目前总股本的0.0619%，增持金额合计1019.31万元(不含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1217388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300676","BK0221","BK0196","BK0042","BK0197","BK0046"],"gpt_icon":0},{"id":"2486296829","title":"华大基因：11月26日高管赵立见增持股份合计5.86万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486296829","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486296829?lang=zh_cn&edition=full","pubTime":"2024-11-27 21:01","pubTimestamp":1732712478,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月27日市场公开信息、上市公司公告及交易所披露数据整理，华大基因最新董监高及相关人员股份变动情况：2024年11月26日公司董事,高管赵立见共增持公司股份5.86万股，占公司总股本为0.0141%。变动期间公司股价下跌1.24%，11月26日当日收盘报44.64元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700037125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0197","BK0196","300676","BK0221","BK0046"],"gpt_icon":0},{"id":"2486911378","title":"华大基因高管频繁增持背后：净利润首亏与研发转化率降低成焦点","url":"https://stock-news.laohu8.com/highlight/detail?id=2486911378","media":"大消费之家","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486911378?lang=zh_cn&edition=full","pubTime":"2024-11-27 12:09","pubTimestamp":1732680540,"startTime":"0","endTime":"0","summary":"随着这次上层股权的调整，汪建个人在华大基因的持股比例增加至35.75%。此外，华大基因还透露了控股股东华大控股计划减持公司股份的消息。直到2017年，备受瞩目的华大基因在创业板上市，四个月后，公司市值一举突破千亿大关，汪建再次成为公众焦点。截至2024年9月30日，华大基因的应收账款高达18.29亿元，占2023年全年营收的42%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-27/doc-incxnmtq6896529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300676"],"gpt_icon":0},{"id":"2486595538","title":"华大基因实控人罕见方式增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2486595538","media":"媒体滚动","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486595538?lang=zh_cn&edition=full","pubTime":"2024-11-27 00:20","pubTimestamp":1732638000,"startTime":"0","endTime":"0","summary":" 素有“基因狂人”之称的华大基因实控人汪建持股比例将进一步提升。 11月26日，华大基因公告称，公司控股股东华大控股计划以大宗交易方式减持公司股份不超过831.64万股，即不超过公司总股本比例的2%。华大基因相关负责人如是说。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-11-27/doc-incxmkhe4030978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300676","BK0197","BK0196","BK0046","BK0221","BK0042"],"gpt_icon":0},{"id":"2486148400","title":"华大基因：华大控股计划以大宗交易方式减持不超2%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486148400","media":"中国财富通","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486148400?lang=zh_cn&edition=full","pubTime":"2024-11-26 12:25","pubTimestamp":1732595117,"startTime":"0","endTime":"0","summary":"中国财富通11月26日 - 华大基因（300676）公告称，控股股东深圳华大基因科技有限公司持有公司股份148,773,893股，占公司总股本415,821,575股的35.78%。华大控股计划以大宗交易方式减持公司股份不超过8,316,432股（即不超过公司总股本比例的2%），减持时间区间为本减持计划公告之日起15个交易日后的3个月内进行（2024年12月17日—2025年3月16日）。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=ClqeK%2FhRR7M%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300676","BK0197","BK0196","BK0046","BK0221","BK0042"],"gpt_icon":0},{"id":"2486698080","title":"11月25日上市公司减持汇总：华大基因等8股拟减持（表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2486698080","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486698080?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:33","pubTimestamp":1732545180,"startTime":"0","endTime":"0","summary":"据统计，11月25日，盘后包括李子园、中富通（维权）、华大基因、山外山、华东重机、东威科技、杭州银行、芯动联科在内的8家A股上市公司披露减持情况。\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-25/doc-incxhyyz1974131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300676","BK0197","BK0196","BK0046","BK0221","BK0042"],"gpt_icon":0},{"id":"2486688320","title":"华大基因实控人汪建收购王俊全部股份，持股比例持续提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2486688320","media":"格隆汇APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486688320?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:16","pubTimestamp":1732544160,"startTime":"0","endTime":"0","summary":"根据公告，公司实控人汪建通过全资控股公司已经全数收购自然人王俊持有华大控股10.5%的股份，在华大控股的上层股权调整后，公司实际控制人汪建持有公司股份比例增加至35.75%。同时，华大基因还披露了公司控股股东华大控股拟减持公司股份的计划，华大控股将以大宗交易方式，在公告之日起15个交易日后的3个月内，减持不超过公司总股本比例2%的股份。自华大基因上市以来，汪建始终坚守其不减持的承诺。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzAwNjExNDkyOA==&mid=2649858652&idx=3&sn=58571e29af1f7f1c2f2c19390d82d271&chksm=83175943b460d055c4678ee2078d097d70bc50bfc84383cbe0382415ef9de7afc0e88fd542d2#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK0221","BK0196","BK0197","300676","BK0046","BK0042"],"gpt_icon":0},{"id":"2486813330","title":"华大基因：11月22日高管王玉珏增持股份合计3300股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486813330","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486813330?lang=zh_cn&edition=full","pubTime":"2024-11-25 21:22","pubTimestamp":1732540951,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月25日市场公开信息、上市公司公告及交易所披露数据整理，华大基因最新董监高及相关人员股份变动情况：2024年11月22日公司董事,高管王玉珏共增持公司股份3300.0股，占公司总股本为0.0008%。变动期间公司股价下跌4.23%，11月22日当日收盘报44.8元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112500031189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0221","BK0196","BK0197","300676","BK0046","BK0042"],"gpt_icon":0},{"id":"2486086606","title":"华大基因最新公告：控股股东计划减持公司股份不超过2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486086606","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486086606?lang=zh_cn&edition=full","pubTime":"2024-11-25 20:51","pubTimestamp":1732539073,"startTime":"0","endTime":"0","summary":"华大基因公告，控股股东华大控股计划以大宗交易方式减持公司股份不超过8,316,432股，即不超过公司总股本比例的2%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112500030316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0042","300676","BK0046","BK0221","BK0196"],"gpt_icon":0},{"id":"2486713085","title":"华大基因：控股股东华大控股拟减持不超2%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486713085","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486713085?lang=zh_cn&edition=full","pubTime":"2024-11-25 20:46","pubTimestamp":1732538763,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0221","BK0197","300676","BK0042","BK0046","BK0196"],"gpt_icon":0},{"id":"2486863110","title":"华大基因(300676.SZ)控股股东华大控股拟减持不超2%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486863110","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486863110?lang=zh_cn&edition=full","pubTime":"2024-11-25 20:43","pubTimestamp":1732538605,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华大基因(300676.SZ)公告，公司控股股东深圳华大基因科技有限公司(简称华大控股)计划以大宗交易方式减持公司股份不超过831.64万股(即不超过公司总股本比例的2%)，减持时间区间为2024年12月17日—2025年3月16日。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1215637.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0221","BK0196","BK0197","300676","BK0046","BK0042"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-07-14","address":"广东省深圳市盐田区洪安三街21号华大综合园7栋7层-14层","stockEarnings":[{"period":"1week","weight":-0.0425},{"period":"1month","weight":-0.0152},{"period":"3month","weight":0.2376},{"period":"6month","weight":0.222},{"period":"1year","weight":-0.0606},{"period":"ytd","weight":-0.0782}],"companyName":"深圳华大基因股份有限公司","boardCode":"AI0074","perCapita":"6279股","boardName":"专业技术服务业","registeredCapital":"41582万元","compareEarnings":[{"period":"1week","weight":-0.0104},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.1705},{"period":"6month","weight":0.1274},{"period":"1year","weight":0.1497},{"period":"ytd","weight":0.1265}],"survey":" 深圳华大基因股份有限公司的主营业务为通过基因检测,质谱检测,生物信息分析等多组学大数据技术手段，为科研机构,企事业单位,医疗机构,社会卫生组织等提供研究服务和精准医学检测综合解决方案。公司主要产品包括孕期营养检测、人体氨基酸检测、人体维生素检测等。公司荣获“2022年度ESG最佳社会责任企业”、“2023医疗器械出海最佳战略布局企业”、“2022年度投资者关系金奖杰出IR公司”，“2023环境、社会及治理（ESG）年度案例”等多项社会荣誉或奖项，有效提升了公司的品牌知名度和影响力。","serverTime":1735019506471,"listedPrice":13.64,"stockholders":"65696人(较上一季度减少1.24%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华大基因(300676)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华大基因(300676)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华大基因,300676,华大基因股票,华大基因股票老虎,华大基因股票老虎国际,华大基因行情,华大基因股票行情,华大基因股价,华大基因股市,华大基因股票价格,华大基因股票交易,华大基因股票购买,华大基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华大基因(300676)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华大基因(300676)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}